For Canadians dealing with obesity and related metabolic conditions, this development matters because current options, while effective, still leave many patients short of their goals
With all that said, the FDA's main concern is that anyone who is compounding or helping out with the national shortage should be using the exact form in the FDA approved commercial products, the Semaglutide base
[DOI] [PMC free article] [PubMed] [Google Scholar] 71
Always check your retatrutide shelf life against your reconstitution date
10.1185/030079904X1980 51 PapadopoulosV
They should not be used by individuals with type 1 diabetes, during pregnancy or whilst breastfeeding, or by those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) a hereditary condition associated with tumours of the endocrine glands